{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T19:49:51Z","timestamp":1788637791641,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tice.2024.102671","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T07:51:40Z","timestamp":1734335500000},"page":"102671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Oxymatrine ameliorates epithelial mesenchymal transition in IgA nephropathy induced rats"],"prefix":"10.1016","volume":"93","author":[{"given":"Rajiv","family":"Jash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himangshu Sekhar","family":"Maji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnab","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousik","family":"Maparu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket","family":"Seksaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arghya","family":"Paria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijit","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anwesha","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bornika","family":"Chattaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DS NB K.","family":"Prasanth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2024.102671_bib1","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s40264-014-0196-1","article-title":"Drug-Induced Hyperkalemia","volume":"37","author":"Ben Salem","year":"2014","journal-title":"Drug Saf."},{"key":"10.1016\/j.tice.2024.102671_bib2","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1056\/NEJMra020109","article-title":"IgA nephropathy","volume":"347","author":"Donadio","year":"2002","journal-title":"New Engl. J. Med. Rev."},{"key":"10.1016\/j.tice.2024.102671_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ilar.47.1.5","article-title":"Design and statistical methods in studies using animal models of development","volume":"47","author":"Festing","year":"2006","journal-title":"ILAR J."},{"key":"10.1016\/j.tice.2024.102671_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00120-023-02268-1","article-title":"IgA nephropathy","volume":"63","author":"Floege","year":"2024","journal-title":"Urologie"},{"key":"10.1016\/j.tice.2024.102671_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00281-021-00888-3","article-title":"Current treatment of IgA nephropathy","volume":"43","author":"Floege","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.tice.2024.102671_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20190103","article-title":"Transforming growth factor\u2013\u00df in tissue fibrosis","volume":"217","author":"Frangogiannis","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tice.2024.102671_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12882-019-1306-1","article-title":"Blood urea nitrogen is independently associated with renal outcomes in Japanese patients with stage 3\u20135 chronic kidney disease: a prospective observational study","volume":"20","author":"Seki","year":"2019","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.tice.2024.102671_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep01629","article-title":"Oxymatrine prevents NF-\u03baB nuclear translocation and ameliorates acute intestinal inflammation","volume":"3","author":"Guzman","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2024.102671_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.semdp.2020.03.001","article-title":"IgA nephropathy: A brief review","volume":"37","author":"Hassler","year":"2020","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.tice.2024.102671_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s40620-023-01839-x","article-title":"The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience","author":"He","year":"2024","journal-title":"J. Nephrol."},{"key":"10.1016\/j.tice.2024.102671_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules27196209","article-title":"Oxymatrine alleviates gentamicin-induced renal injury in rats","volume":"27","author":"Kang","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.tice.2024.102671_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104541","article-title":"Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: From bench to bedside","volume":"151","author":"Lan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.tice.2024.102671_bib13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1742-7843.2010.00653.x","article-title":"In vitro anti-tumour activities of quinolizidine alkaloids derived from sophora flavescens ait","volume":"108","author":"Lin","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.tice.2024.102671_bib14","first-page":"1","article-title":"Oxymatrine inhibits renal tubular EMT induced by high glucose via upregulation of SnoN and inhibition of TGF-\u03b21\/Smad signaling pathway","volume":"11","author":"Liu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tice.2024.102671_bib15","first-page":"1","article-title":"Oxymatrine exerts anti-fibrotic effects in a rat model of hepatic fibrosis by suppressing endoplasmic reticulum stress","volume":"48","author":"Liu","year":"2020","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.tice.2024.102671_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1053\/j.ajkd.2018.10.011","article-title":"Update on the native kidney biopsy: core curriculum 2019","volume":"73","author":"Luciano","year":"2019","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.tice.2024.102671_bib17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00281-021-00882-9","article-title":"Complement activation in IgA nephropathy","volume":"43","author":"Medjeral-Thomas","year":"2021","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.tice.2024.102671_bib18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/sj.ki.5002185","article-title":"Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels","volume":"71","author":"Moldoveanu","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.tice.2024.102671_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10157-019-01735-4","article-title":"Clinical and histological features and therapeutic strategies for IgA nephropathy","volume":"23","author":"Moriyama","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.tice.2024.102671_bib20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/ndt\/gfae056","article-title":"Hyperkalemia treatment standard","volume":"39","author":"Palmer","year":"2024","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.tice.2024.102671_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms20246199","article-title":"The role of IgA in the pathogenesis of IgA nephropathy","volume":"20","author":"Per\u0161e","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tice.2024.102671_bib22","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMc1600141","article-title":"Intensive Supportive Care plus Immunosuppression in IgA Nephropathy","volume":"374","author":"Review","year":"2016","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.tice.2024.102671_bib23","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1248\/bpb.32.1728","article-title":"TJN-259 improves mesangial lesions in experimental immunoglobulin A nephropathy in ddY mice","volume":"32","author":"Sadakane","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.tice.2024.102671_bib24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11418-017-1144-z","article-title":"Enzyme-linked immunosorbent assay for the quantitative\/qualitative analysis of plant secondary metabolites","volume":"72","author":"Sakamoto","year":"2018","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.tice.2024.102671_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.semnephrol.2018.05.013","article-title":"Epidemiology of IgA Nephropathy: A Global Perspective","volume":"38","author":"Schena","year":"2018","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.tice.2024.102671_bib26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s11560-020-00452-4","article-title":"IgA nephropathy","volume":"15","author":"Seikrit","year":"2020","journal-title":"Nephrologe"},{"key":"10.1016\/j.tice.2024.102671_bib27","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10157-019-01700-1","article-title":"New strategies and perspectives on managing IgA nephropathy","volume":"23","author":"Selvaskandan","year":"2019","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.tice.2024.102671_bib28","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-007-2512-6_100","article-title":"Biobanking","author":"Shickle","year":"2014","journal-title":"Handb. Glob. Bioeth."},{"key":"10.1016\/j.tice.2024.102671_bib29","first-page":"6","article-title":"Progress in pathogenesis of immunoglobin a nephropathy","volume":"12","author":"Stanley","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.tice.2024.102671_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125906","article-title":"Mesoporous polydopamine based biominetic nanodrug ameliorates liver fibrosis via antioxidation and TGF-\u03b2\/SMADS pathway","volume":"248","author":"Tang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.tice.2024.102671_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24983","article-title":"Altenusin, a fungal metabolite, alleviates TGF-& #x3b2;1-induced EMT in renal proximal tubular cells and renal fibrosis in unilateral ureteral obstruction.","volume":"10","author":"Thipboonchoo","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.tice.2024.102671_bib32","first-page":"4747","article-title":"Oxymatrine protects against the effects of cardiopulmonary resuscitation via modulation of the TGF-\u03b21\/Smad3 signaling pathway","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tice.2024.102671_bib33","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3109\/0886022X.2016.1164185","article-title":"Oxymatrine inhibits renal fibrosis of obstructive nephropathy by downregulating the TGF-\u03b21-Smad3 pathway","volume":"38","author":"Wang","year":"2016","journal-title":"Ren. Fail."},{"issue":"6","key":"10.1016\/j.tice.2024.102671_bib34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1159\/000485346","article-title":"Therapeutic effects of FK506 on IgA Nephropathy Rat","volume":"42","author":"Wei","year":"2017","journal-title":"Kidney Blood Press. Res."},{"key":"10.1016\/j.tice.2024.102671_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12519-009-0040-3","article-title":"Expression and significance of TGF-\u03b21\/Smad signaling pathway in children with IgA nephropathy","volume":"5","author":"Wu","year":"2009","journal-title":"World J. Pediatr."},{"key":"10.1016\/j.tice.2024.102671_bib36","article-title":"Accumulation of renal fibrosis in hyperuricemia rats is attributed to the recruitment of mast cells, activation of the TGF-\u03b21\/Smad2\/3 pathway, and aggravation of oxidative stress","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624003720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816624003720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T23:34:34Z","timestamp":1740785674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816624003720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":36,"alternative-id":["S0040816624003720"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2024.102671","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxymatrine ameliorates epithelial mesenchymal transition in IgA nephropathy induced rats","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2024.102671","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102671"}}